Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE® Diagnostic Testing Platform Test detects sensitization to four common respiratory allergens in United States Scheduled to be commercially available in the US in 2018 Source: businesswire.com - October 20, 2017 01:00 AM Eastern Daylight Time LAUSANNE, Switzerland--(BUSINESS WIRE)--Abionic SA, a developer of disrupter
World’s Fastest Sepsis Test from Abionic Produces Result in Five Minutes when Tested in patients at London and Zurich Hospitals The UK National Institute for Health and Care Excellence (NICE) is urging hospital staff to treat people with life-threatning sepsis symptoms within one hour University College London Hospitals (UCLH) evaluation highlighted that the
Abionic wins the Swiss Economic Forum award
Revolutionary treatment could save thousands of lives, and may soon be introduced in the NHS Sepsis is a life-threatening condition caused by your own body's immune system It occurs when your body overreacts to any infection, even to a small cut or bite The new test has the potential to save hundreds of
PRESS RELEASE: BIOMEDICAL SCREENING DEVICES SOON IN YOUR PHARMACY Source: Abionic.com Biomedical screening devices soon in your pharmacy Lausanne, Switzerland, May 11, 2016 - Starting in November, the AbioSCOPE, a biomedical screening device, in particular for allergies and iron deficiency, will progressively be available in pharmacies in Switzerland. Abionic, the company which developed
Abionic has been ranked 2nd best Swiss Startup in 2015 A revolution with regulatory approval. The system of Abionic for meaningful allergy tests in doctor’s offices and pharmacies shakes up a market worth billions in revenue. Source: venturelab.ch – 13 october 2015 Abionic has been located in the EPFL Innovation Park in Lausanne